Found 6 matching trials
Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Gemcitabine and Carboplatin in Metastatic Triple Negative Breast Cancer (mTNBC)
PHASE2This was a study to investigate the potential clinical benefit of trilacicl...
Location
Arizona Oncology Associates, PC - HOPE
Comparison of Efficacy of Topical Westerhoff Formula Cream Vs Topical 4% Hydroquinone for the Treatment of Melasma
PHASE4study was conducted on middle aged male and female, including families and ...
Location
Dermatology Department of Tertiary Care Hospital
Oral Isotretinoin in Melasma a Randomized Controlled Trial
PHASE1Melasma is a common refractory acquired hyperpigmentation of the skin havin...
Location
Dermatology department, Zagazig University Hospitals, Faculty of Medicine, Zagazig University
Triplenex (triple Fixed Combination) Use Evaluation in Patients with Glaucoma
PHASE4This project purpose is to evaluate the effectiveness, ocular surface quali...
Status
Active Not Recruiting
Location
Federal University of São Paulo
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
PHASE1The study's purpose is to establish the safety and tolerability of IMA203/I...
Location
Stanford Cancer Institute
Trial Comparing Cataract Surgery With Triple-DMEK in Patients With Cataract and Fuchs Endothelial Corneal Dystrophy
NAThe purpose of the study is to investigate whether there is a difference in...
Location
Department of Ophthalmology, Aarhus University Hospital